Francois Brisebois
Stock Analyst at Oppenheimer
(3.7)
Main Sectors:
36 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeuti... | Maintains: Outperform | 7 8 | 5.99 | 33.56% | 3 | Sep 8, 2025 | |
SVRA Savara | Maintains: Outperform | 5 6 | 3.52 | 70.45% | 6 | Aug 15, 2025 | |
SNSE Sensei Biotherapeuti... | Maintains: Outperform | 70 80 | 8.87 | 801.92% | 2 | Mar 28, 2025 | |
ABEO Abeona Therapeutics | Initiates Coverage On: Outperform | 16 | 5.44 | 194.12% | 1 | Mar 5, 2025 | |
OVID Ovid Therapeutics | Upgrades: Outperform | 4 | 1.73 | 131.21% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 65 72 | 56.29 | 27.91% | 7 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 59 61 | 27.51 | 121.74% | 6 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 20 20 | 10.67 | 87.44% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 28 | 5.8 | 382.76% | 2 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 29 30 | 15.34 | 95.57% | 8 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 143 163 | 52.44 | 210.83% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 55 55 | 13.15 | 318.25% | 5 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 15 15 | 19.05 | -21.26% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 6 6 | 6.94 | -13.54% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 11 11 | 3.01 | 265.45% | 6 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 14 14 | 23.26 | -39.81% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 25 | 4.51 | 454.32% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 65 | 14.89 | 336.53% | 5 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 10 10 | 5.07 | 97.24% | 2 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 5 | n/a | n/a | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 152 | 5.82 | 2511.68% | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 63 36 | 17.89 | 101.23% | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 4 | n/a | n/a | 3 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 100 60 | n/a | n/a | 3 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 7200 5400 | 1.66 | 325201.2% | 2 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 80 100 | n/a | n/a | 1 | Sep 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 11 | 3.09 | 255.99% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 23 | n/a | n/a | 2 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 18 | 4.63 | 288.77% | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 6 | n/a | n/a | 1 | Apr 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 5.8 | 762.07% | 1 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 19 | n/a | n/a | 1 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | n/a | n/a | 1 | Mar 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 3240 | 1.39 | 232993.53% | 1 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 99 130 | n/a | n/a | 3 | Jan 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | n/a | n/a | 1 | Nov 8, 2017 |